TVGN
Tevogen Bio Holdings·NASDAQ
--
--(--)
--
--(--)
TVGN Filings
Filing Date
Form Description
Form Type
2026-03-31
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-31 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-25
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-25
Form 8-K - Current report
Key Events
2026-03-25 · Key Events
Form 8-K - Current report
2026-03-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-04
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-04 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-04
Form 8-K - Current report
Key Events
2026-03-04 · Key Events
Form 8-K - Current report
2026-02-26
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-26 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-25
Form 8-K - Current report
Key Events
2026-02-25 · Key Events
Form 8-K - Current report
2026-02-06
Form 144 - Report of proposed sale of securities
Ownership
2026-02-06 · Ownership
Form 144 - Report of proposed sale of securities
2026-01-30
Form 8-K - Current report
Key Events
2026-01-30 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
